New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets

According to the CDC, about 40-45% of adults in the U.S. have hypertension.

Indicated for the treatment of hypertension, Camber Pharmaceuticals has added Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets to its growing portfolio of treatment options.

Generic to Tribenzor®, Camber’s Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets are available in 30 and 90 ct bottles of:

  • 20 mg/5 mg/12.5mg
  • 40 mg/5 mg/12.5 mg
  • 40 mg/5 mg/25 mg
  • 40 mg/10 mg/12.5 mg
  • 40 mg/10 mg/25 mg

Click to learn more